Chronic iloprost administration in scleroderma patients effect on disease progression, as assessed by skin fibrosis evaluation. A randomized, controlled, blind-observer, multicenter phase III study. Chronic iloprost administration in scleroderma patients effect on disease progression, as assessed b ...
Chronic iloprost administration in scleroderma patients effect on disease progression, as assessed by skin fibrosis evaluation. A randomized, controlled, blind-observer, multicenter phase III study. Chronic iloprost administration in scleroderma patients effect on disease progression, as assessed b ...
Disease progression in scleroderma. MedDRA version: 6.1;Level: HLT;Classification code 10039711